Kyverna Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Kyverna Therapeutics's estimated annual revenue is currently $31.6M per year.
- Kyverna Therapeutics's estimated revenue per employee is $189,341
Employee Data
- Kyverna Therapeutics has 167 Employees.
- Kyverna Therapeutics grew their employee count by 29% last year.
Kyverna Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Product Officer | Reveal Email/Phone |
3 | Chief Financial Officer | Reveal Email/Phone |
4 | Chief Business Officer | Reveal Email/Phone |
5 | Chief Human Resources Officer | Reveal Email/Phone |
6 | Chief Business Officer | Reveal Email/Phone |
7 | Chief Medical and Development Officer | Reveal Email/Phone |
8 | Head Human Resources | Reveal Email/Phone |
9 | Head Medical Affairs, Europe | Reveal Email/Phone |
10 | VP, Head GxP Quality | Reveal Email/Phone |
Kyverna Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Kyverna Therapeutics?
Kyverna is a cell therapy company engineering and developing a new class of curative living medicines for inflammatory and autoimmune diseases. Using its SmarTcellâ„¢ approach which includes synReg-T cell and synNotch CAR-T technology platforms, Kyverna reprograms T cells to target and selectively suppress or eliminate autoreactive immune cells. The company's goal is to develop therapies that are selective, potent and durable to tame autoimmunity. synNotch is a trademark of Gilead/Kite.
keywords:N/A
N/A
Total Funding
167
Number of Employees
$31.6M
Revenue (est)
29%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Kyverna Therapeutics News
The Kyverna therapeutic platform combines advanced T-cell engineering and synthetic biology technologies to suppress or eliminate the...
Kyverna Therapeutics, a cell therapy company engineering a new class of therapies for autoimmune diseases, has closed an oversubscribed $85m...
Other Companies in Emeryville
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $38.8M | 168 | 11% | N/A |
#2 | $62.8M | 174 | 8% | N/A |
#3 | $64.2M | 178 | 21% | N/A |
#4 | $30.7M | 186 | 21% | N/A |
#5 | $49.4M | 198 | 68% | N/A |